Cancer-stromal interactions in scirrhous gastric carcinoma.
about
Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer InvasionStromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interactionStromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cellsPhase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.The significance of a nineteenth century definition in the era of genomics: linitis plastica.MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitorsThe HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells.Bone marrow-derived stromal cells are associated with gastric cancer progression.NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivoPancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma.A digest on the role of the tumor microenvironment in gastrointestinal cancers.Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation.Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN.Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells.Discoidin domain receptor 1 activity drives an aggressive phenotype in bladder cancer.Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling.CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.Tks5 activation in mesothelial cells creates invasion front of peritoneal carcinomatosis.Characterization and potential roles of bone marrow-derived stromal cells in cancer development and metastasisDiffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity
P2860
Q26782289-40F940D5-8526-4569-857F-0C619CFFEE4BQ27312218-A515C62B-3620-434E-B31D-434697DD25F8Q27333747-62E4AD68-CA6A-4F2B-B003-F82F11688FBFQ33407676-83E9F735-4E54-4EE3-86A1-26E0AB98FDCDQ33757722-270A07E5-9492-46BE-A26B-E611E0659520Q33876785-83D1A70B-AC05-4A66-B354-A1F5B303E832Q35051479-409638DD-10AA-4E7B-B27A-DB32EF6AE1D0Q35051588-BCA15D35-72B0-42F6-9627-91A2AEA733C0Q35818450-5128AE85-5031-46CF-9055-79BCE9526734Q35909669-679E7FBA-F781-43CB-856F-0A70B7BB2765Q36058744-B2165A3D-16D8-4BC7-9612-26F50F0BB368Q36093878-C08C1424-1BAE-4A21-9713-91BCCA1FF525Q36265839-3B3CD9E6-90C9-4CB2-B066-7E9726DEC5DAQ36645236-4B045568-7C33-4B03-9B02-1A62C48A790DQ37323058-61353622-0F16-4BDB-8CFF-FF5288E5F849Q37826352-4A2B67A2-4DD1-4208-A8C2-E1D902AD8979Q38395391-8BC34902-CDA3-460D-AE26-8AC552405C38Q38556589-7EE990E4-6372-47DA-B8BD-26171174E63FQ38617601-665808E1-C71E-4E95-B3CC-E774EFEB5965Q38834166-FCBF9D05-7F44-404D-8543-1EF12078F619Q38839374-9F4C2046-34F0-434C-95DC-BE1D79DE85D0Q38985973-2A9244D0-EFCC-4091-BC24-4F026B968B50Q38993513-0A3EBF97-E260-4E87-870F-33993384541BQ39071833-22BF0401-30B5-42EF-A945-8CBEEC657145Q39399237-7980DB6B-348D-4C60-AF5F-F5A02A0E44EAQ42241972-54A1FA31-413A-4919-83B6-5046E23C6155Q47101405-BEC3B692-A1D7-4128-9381-57498F32999BQ49952398-30D0637B-B952-4691-BCFF-360BED1CA107Q50041880-9073DE3E-1DDB-4CF6-A1D2-A329829C87CBQ53002740-1C81907A-2717-4798-90C8-5E7A670A158FQ54333214-7B0705D3-C455-4A51-ACA3-1885077BA6EEQ57116617-14738B3A-C912-4DE1-9399-9FF33AC98A25Q58772957-2B16C2B8-54A3-4A97-9837-7666342EB5FC
P2860
Cancer-stromal interactions in scirrhous gastric carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cancer-stromal interactions in scirrhous gastric carcinoma.
@en
type
label
Cancer-stromal interactions in scirrhous gastric carcinoma.
@en
prefLabel
Cancer-stromal interactions in scirrhous gastric carcinoma.
@en
P2860
P1433
P1476
Cancer-stromal interactions in scirrhous gastric carcinoma.
@en
P2093
Kosei Hirakawa
Masakazu Yashiro
P2860
P2888
P304
P356
10.1007/S12307-010-0036-5
P577
2010-01-26T00:00:00Z